Mesoblast Ownership | Who Owns Mesoblast?
Mesoblast Ownership Summary
Mesoblast is owned by 0.34% institutional investors, 0.06% insiders, and 99.60% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 0.06% of MESO shares. iShares Biotechnology ETF is the top mutual fund, with 0.39% of its assets in Mesoblast shares.
MESO Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Mesoblast | 0.34% | 0.06% | 99.60% |
Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock funding, inc. /de | 727.25K | 0.06% | $14.40M |
Ubs group | 168.25K | 0.01% | $3.33M |
Susquehanna group, llp | 153.98K | 0.01% | $3.05M |
Summit x | 145.66K | 0.01% | $2.88M |
Jane street group | 102.17K | 0.01% | $2.02M |
Citigroup | 100.00K | 0.01% | $1.98M |
Prosperity wealth management | 93.25K | 0.01% | $1.85M |
Penbrook management | 91.08K | 0.01% | $1.80M |
Rockbridge investment management, lcc | 49.15K | 0.00% | $973.17K |
Lazari capital management | 45.47K | 0.00% | $900.25K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Penbrook management | 91.08K | 1.23% | $1.80M |
Prosperity wealth management | 93.25K | 0.76% | $1.85M |
Summit x | 145.66K | 0.64% | $2.88M |
Lazari capital management | 45.47K | 0.36% | $900.25K |
Fi3 financial advisors | 36.63K | 0.27% | $725.17K |
Rockbridge investment management, lcc | 49.15K | 0.12% | $973.17K |
Chapin davis | 15.00K | 0.04% | $122.55K |
Tobias financial advisors | 10.00K | 0.04% | $198.00K |
Pine valley investments ltd liability | 20.93K | 0.02% | $414.43K |
China universal asset management | 6.78K | 0.01% | $134.16K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock funding, inc. /de | 727.25K | 0.00% | 645.77K |
Ubs group | 168.25K | 0.00% | 168.25K |
Citigroup | 100.00K | 0.00% | 100.00K |
Susquehanna group, llp | 153.98K | 0.00% | 37.24K |
Cubist systematic strategies | 35.19K | 0.00% | 24.87K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Group one trading | - | - | -253.38K |
Oaktree capital management lp | - | - | -179.59K |
Strategic financial concepts | - | - | -138.60K |
Oaktree fund advisors | - | - | -47.91K |
Xy capital | - | - | -29.85K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Ubs group | 168.25K | 0.00% | 168.25K | $3.33M |
Citigroup | 100.00K | 0.00% | 100.00K | $1.98M |
Vanguard personalized indexing management | 12.80K | 0.00% | 12.80K | $253.46K |
Royal bank of canada | 7.50K | - | 7.50K | $149.00K |
China universal asset management | 6.78K | 0.01% | 6.78K | $134.16K |
Sold Out
Holder | Change |
---|---|
Sjs investment consulting | -48.00 |
Ronald blue trust | -91.00 |
Advisors preferred | -4.58K |
Quadrant capital group | -6.53K |
Sageworth trust | -10.00K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 73 | 7.35% | 3,846,194 | 21.24% | - | 326.03% | 38 | -19.15% | 17 | 112.50% |
Dec 31, 2024 | 63 | 34.04% | 2,979,315 | 92.78% | - | 10.82% | 42 | 90.91% | 8 | -33.33% |
Sep 30, 2024 | 45 | - | 1,532,837 | 3.28% | 1 | 68.66% | 21 | -32.26% | 12 | 300.00% |
Jun 30, 2024 | 45 | 40.63% | 1,484,211 | 36.87% | 1 | 124.54% | 31 | 82.35% | 3 | -72.73% |
Mar 31, 2024 | 32 | - | 1,084,385 | -7.60% | 1 | 310.73% | 17 | 30.77% | 11 | 37.50% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Biotechnology ETF | 498.48K | 0.39% | 4.26K |
iShares Nasdaq US Biotech ETF USD Acc | 26.77K | 0.02% | - |
Fidelity Nasdaq Composite Index | 18.25K | 0.01% | - |
VT Downing Global Investors F Inc | 12.50K | 0.01% | - |
China Universal NASDAQ Bio-Tch ETF(QDII) | 6.78K | 0.01% | 6.78K |
ActivePassive International Equity ETF | 4.97K | 0.00% | - |
Quantified Global Fund Investor | 4.58K | 0.00% | 3.17K |
ProShares Ultra Nasdaq Biotechnology | 1.67K | 0.00% | - |
Invesco Nasdaq Biotechnology ETF | 1.62K | 0.00% | - |
Xtrackers MSCI Genomic HC Inno ETF 1C | 1.40K | 0.00% | 1.40K |
MESO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools